---
title: "Bruker Projects Flat to Low-Single Digit Organic Revenue Growth for 2026"
description: "Bruker Corporation has announced preliminary financial guidance for Q4 2025 and full year 2026, expecting Q4 revenue between $965 million and $970 million. The company projects flat to low-single digi"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/272301254.md"
published_at: "2026-01-12T17:01:14.000Z"
---

# Bruker Projects Flat to Low-Single Digit Organic Revenue Growth for 2026

> Bruker Corporation has announced preliminary financial guidance for Q4 2025 and full year 2026, expecting Q4 revenue between $965 million and $970 million. The company projects flat to low-single digit organic revenue growth for 2026, with non-GAAP organic operating margins expanding by 250 to 300 basis points and non-GAAP earnings per share increasing by double digits year-over-year.

Bruker Corporation has provided preliminary financial guidance for the fourth quarter and full year 2026. The company expects fourth quarter 2025 revenue to be between $965 million and $970 million, with its Bruker Scientific Instruments segments reporting a book-to-bill ratio above 1.0. For the full year ending December 31, 2026, Bruker anticipates organic revenue growth will be flat to up in the low-single digits compared to 2025. Additionally, non-GAAP organic operating margins are expected to expand by 250 to 300 basis points, while non-GAAP earnings per share are projected to increase by double digits year-over-year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-010106), on January 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [BRKR.US - Bruker](https://longbridge.com/en/quote/BRKR.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 这些分析师在布鲁克公布第四季度业绩后下调了他们的预测 | 布鲁克公司（NASDAQ:BRKR）公布了混合的第四季度业绩，收益为每股 59 美分，低于预期的 65 美分，但销售额为 9.772 亿美元，超过了预期的 9.608 亿美元。该公司预计 2026 财年的调整后每股收益为 2.10 至 2. | [Link](https://longbridge.com/en/news/275927262.md) |
| 布鲁克公司第四季度收入因生物制药市场的复苏而超出预期 | 布鲁克公司报告 2025 年第四季度收入为 9.772 亿美元，超出分析师预期的 9.6083 亿美元，尽管同比增长持平。然而，调整后的每股收益为 0.59 美元，低于 0.65 美元的预期。公司预计 2026 财年的收入增长为 4% 至  | [Link](https://longbridge.com/en/news/275752855.md) |
| Laureate Edu｜10-K：2025 财年营收 17.02 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276331237.md) |
| Orange 预计到 2028 年有机现金流将实现两位数增长，并提高股息 | Orange 预计到 2028 年实现两位数的有机现金流增长；提高股息 | [Link](https://longbridge.com/en/news/276310740.md) |
| UL Solutions Inc.公布 2025 年第四季度及全年业绩表现强劲 | 2 月 19 日（路透社）- UL Solutions Inc：UL SOLUTIONS INC. 报告 2025 年第四季度和全年强劲业绩，宣布 2026 年增长展望并增加季度股息。UL SOLUTIONS INC：2026 年展望为中个 | [Link](https://longbridge.com/en/news/276334379.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.